Amkay Products Peer Comparison

BSE: 544169

₹58.79

₹1.79 (3.14%)

As on 31-Aug-2026IST

Market cap

₹51 Cr

Revenue (TTM)

₹38 Cr

P/E Ratio

22

P/B Ratio

2.1

Div. Yield

0 %

Edit

	Amkay Products	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Market cap (₹ Cr)	51	17,871	1,389	579	320
Revenue (₹ Cr)	38	1,997	314	92	153
Net Profit (₹ Cr)	3.34	307.01	24.51	4.71	4.34
Net Margin (%)	8.41	14.56	7.60	5.06	2.70
RoE (%)	19.60	10.63	13.94	4.92	2.29
Price to Earnings	22.02	56.72	24.93	47.12	73.70
Price-To-Book	2.11	5.62	6.56	5.79	1.74

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Amkay Products	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Operating Revenue	38.39	1,669.83	313.78	92.43	109.66
Total Income	39.71	1,758.96	322.58	93.00	122.37
Total Expenditure	34.26	1,214.12	239.29	82.12	117.47
EBITDA	4.13	455.71	74.49	10.31	-7.81
Depreciation	0.83	83.18	7.32	3.89	2.34
EBIT	3.30	372.53	67.17	6.42	-10.15
Interest	0.32	14.32	14.81	0.41	1.21
Other Income	1.32	89.13	8.80	0.57	12.71
Exceptional Items	--	--	-16.97	--	--
Profit before Tax	4.30	452.52	44.19	6.59	1.34
Provision for Tax	0.96	113.96	19.68	1.88	0.50
Profit after Tax	3.34	338.56	24.51	4.71	0.85

Liabilities (₹ Cr)

	Amkay Products	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Shareholder's Funds	24.07	2,765.66	189.95	98.04	194.29
Minority Interest	--	--	--	--	--
Non-Current Liabilities	0.87	56.40	85.42	14.44	-0.18
Current Liabilities	4.69	457.71	179.14	18.62	12.40
Total Liabilities	29.89	3,279.77	455.49	131.33	209.98

Assets (₹ Cr)

	Amkay Products	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Non-Current Assets	12.47	1,269.89	189.87	76.67	16.55
Current Assets	17.17	2,009.87	264.64	54.44	189.95
Total Assets	29.89	3,279.77	455.49	131.33	209.98
Total Debt*	2.64	177.65	166.29	17.82	2.37
Net Current Assets	12.47	1,552.17	85.50	35.81	177.55
Contingent Liabilities	0.92	77.12	--	5.29	0.02

Cashflow (₹ Cr)

	Amkay Products	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Cash From Operating Activities	-0.32	233.05	-1.28	3.02	-19.08
Cash Flow from Investing Activities	-5.84	-1,187.18	-59.13	-14.74	8.44
Cash from Financing Activities	7.59	950.51	53.34	-0.60	-0.17
Net Cash Inflow / Outflow	1.43	-3.63	-7.07	-12.32	-10.81

Ratios

Profitability Ratios

	Amkay Products	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
ROCE (%)	21.89	20.37	19.19	6.16	1.31
ROE (%)	19.60	16.01	13.94	4.92	0.44
ROA (%)	14.10	12.99	6.18	3.60	0.42
EBIT Margin (%)	14.18	32.63	26.54	11.77	4.46
Net Margin (%)	8.41	19.25	7.60	5.06	0.69
Cash Profit Margin (%)	10.86	25.15	10.15	7.98	2.61

Growth Ratios

	Amkay Products	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Revenue Growth (%)	23.56	21.37	54.08	-24.14	19.29
EBIT Growth (%)	18.88	30.11	103.82	-46.94	1,494.46
Net Profit Growth (%)	26.94	31.09	13.27	-58.34	147.16
EPS Growth (%)	-6.68	24.16	-18.34	-58.34	147.16
Book Value Growth (%)	140.61	88.41	17.38	5.05	0.61

Valuation Ratios

	Amkay Products	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Price / Earnings	10.31	67.10	0.00	48.10	248.64
Price / Book Value	1.43	8.22	0.00	2.31	1.08
Dividend Yield (%)	0.00	0.16	--	0.00	0.00
EV/EBITDA	6.52	41.75	1.45	22.15	17.43
Market Cap (₹ Cr)	34.41	22,718.23	0.00	226.53	210.35

Solvency Ratios

	Amkay Products	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Debt to Equity	0.11	0.06	0.88	0.18	0.01
Short term debt to equity ratio	0.05	0.06	0.29	0.00	0.00
Current Ratio	3.66	4.39	1.48	2.92	15.32
Quick Ratio	1.93	3.77	0.97	1.83	12.10
Interest Coverage	14.57	32.59	3.98	17.26	2.11

Operating Efficiency Ratios

	Amkay Products	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Debtors to sales (%)	15.66	20.94	26.32	23.68	3.03
Asset Turnover	1.62	0.64	0.79	0.82	0.60
Receivable days	47.54	67.43	63.42	66.41	7.39
Inventory Days	65.31	55.13	113.68	71.27	105.87
Payable days	32.60	74.14	143.90	54.28	31.48
Cash Conversion Cycle	80.25	48.42	33.20	83.40	81.78

Annual
Quarterly